Skip to main
IMPL
IMPL logo

Impel Neuropharma (IMPL) Earnings Dates & Reports

Impel Neuropharma (IMPL) Most Recent Earnings

Report Date
Period EndingQ3 2023
Est. EPS-$0.36
Actual EPS-$0.58
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Impel Neuropharma (IMPL) Earnings per Share (EPS) History

Signup for full access
Browse free

Impel Neuropharma (IMPL) Latest Earnings

The value each IMPL share was expected to gain vs. the value each share gained.

Impel Neuropharma (IMPL) reported its most recent earnings on for Q3 2023, posting earnings per share (EPS) of -$0.58. This exceeded analysts' expectations of -$0.36 by 61.11%, marking a Miss.

For comparison, Impel Neuropharma reported EPS of -$1.31 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.

Impel Neuropharma (IMPL) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2023
-$0.36-$0.58+61.11%
DeckReportListen
Q2 2023
-$0.55-$0.31-43.64%
DeckReportListen
Q1 2023
-$0.90-$1.27+41.11%
DeckReportListen
Q4 2022
-$1.11-$0.97-12.61%
DeckReportListen
Q3 2022
-$1.00-$1.31+31.00%
DeckReportListen
View all

Impel Neuropharma (IMPL) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Impel Neuropharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

Impel Neuropharma (IMPL) Earnings FAQs

Impel Neuropharma (IMPL) last reported earnings on Nov 14, 2023 for Q3 2023, posting an EPS of -$0.58, which Miss the estimate of -$0.36 by 61.11%.

For Q3 2023, Impel Neuropharma (IMPL) reported an EPS of -$0.58, missing analysts' estimate of -$0.36 by 61.11%.

For Q3 2023, Impel Neuropharma (IMPL) Miss expectations with an actual EPS of -$0.58 vs. an estimated EPS of -$0.36.

Following the last earnings report on Nov 14, 2023, Impel Neuropharma (IMPL)'s stock price moved — from — to —.

The next Impel Neuropharma (IMPL) earnings call is scheduled for Nov. 14, 2023, where executives will discuss financial results and outlook.

Impel Neuropharma (IMPL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.